News for hackers. Stuff that matters.
Re:FTC Warns Pharma: May Go After Them for Sham Patents Desi... by adolph on Monday September 18, 2023 @06:25PM (#37562951)
At first I thought this was about minor changes to formulations that can be granted new patents, a problem which seems to me to be to be outside the FTC's purview. It looks like the problem is more like out and out fraud:

Brand drug manufacturers are responsible for ensuring their patents are properly listed. Yet certain manufacturers have submitted patents for listing in the Orange Book that claim neither the reference listed drug nor a method of using it.

. . . courts have recognized that improperly listing patents in the Orange Book may constitute an “improper means” of competition. Accordingly, improperly listing patents in the Orange Book may also be worthy of enforcement scrutiny from government and private enforcers under a monopolization theory.

Re:FTC Warns Pharma: May Go After Them for Sham Patents Desi... by AlbertCory on Monday September 18, 2023 @08:08PM (#37564006)
My take: she has a solid case on this. You build credibility by winning. She hasn't done a good job on that.
Re:FTC Warns Pharma: May Go After Them for Sham Patents Desi... by peyton on Monday September 18, 2023 @08:34PM (#37564254)
The FTC’s statement cites a Shkreli case. I wouldn’t get my hopes up.
Re:FTC Warns Pharma: May Go After Them for Sham Patents Desi... by DangitBobby on Tuesday September 19, 2023 @01:07AM (#37565808)
It is quite clearly fraud. For some reason we don't seem to prosecute companies for fraud.